← FDA DRUG APPROVALS

FDA NDA · NDA020176

VITAPED

Sponsor: HOSPIRA

APPLICATION
NDA020176
TYPE
NDA
ORIGINAL APPROVAL
1993-12-29
LATEST ACTION
1993-12-29
ROUTE
INJECTION
DOSAGE FORM
INJECTABLE
MARKETING STATUS
Discontinued

Products

VITAPEDDiscontinued
ASCORBIC ACID N/A,80MG/VIAL, BIOTIN N/A,0.02MG/VIAL, CYANOCOBALAMIN N/A,0.001MG/VIAL, ERGOCALCIFEROL 400 IU/10ML,N/A, FOLIC ACID N/A,0.14MG/VIAL, NIACINAMIDE N/A,17MG/VIAL, PANTOTHENIC ACID N/A,5MG/VIAL, PHYTONADIONE 0.2MG/10ML,N/A, PYRIDOXINE N/A,1MG/VIAL, RIBOFLAVIN N/A,1.4MG/VIAL, THIAMINE N/A,1.2MG/VIAL, VITAMIN A PALMITATE EQ 2,300 UNITS BASE/10ML,N/A, VITAMIN E 7 IU/10ML,N/A · INJECTABLE · INJECTION

Approval history

1993-12-29Type 3 - New Dosage Form · Original · priorityAP
VIEW ON DRUGS@FDA ↗

Related on SPEQ

Pharma industryGMP disciplineFDA drug shortagesFDA enforcement & recalls

Source: FDA Drugs@FDA. SPEQ is not affiliated with the FDA; this is a reference view of public FDA data, not medical, legal, or regulatory advice.

Weekly Briefing

Get the Weekly GxP Briefing

Curated regulatory intelligence — enforcement, recalls, guidance, and quality signals — in one practitioner-grade email each week. Free.

Read a past issue →